Compass Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Compass Capital Management's AMGN Position: Q2 2026 in Review
Compass Capital Management reduced its Amgen (AMGN) stake by 21% in Q2 2026, selling an estimated $171K and leaving 1,845 shares worth $668K. The position accounts for 0.04% of the portfolio, ranked #64.
Compass Capital Management first reported a position in AMGN in Q2 2025 and has held it in 5 quarters since. The position peaked at $825K in Q1 2026. 3,157 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Compass Capital Management held 1,845 shares of Amgen worth $668K as of Q2 2026.
- Compass Capital Management sold 500 Amgen shares in Q2 2026, an estimated $171K.
- Amgen made up 0.04% of Compass Capital Management's portfolio in Q2 2026, its #64 holding.
- Compass Capital Management first reported a position in Amgen in Q2 2025 and has held it in 5 quarters since.
- Compass Capital Management's Amgen position peaked at $825K in Q1 2026.
- 3,157 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Compass Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.